News

Explore the Future of Cell and Gene Therapy in London

Explore the Future of Cell and Gene Therapy in London

London Hosts Pioneers of Cell and Gene Therapy

London is gearing up to be the center of attention for the field of cell and gene therapy (CGT) as industry pioneers gather to discuss the future and advancements of this impactful medical area. The GenScript Biotech Global Forum is set to take place, marking a pivotal moment for professionals amid rapid developments in CGT, a field recognized for its potential to revolutionize treatment paradigms.

The Promise of Cell and Gene Therapy

As advancements propel CGT into a new era, the medical community is witnessing transformative breakthroughs that bridge laboratory innovations with real-world applications. From pioneering genome editing techniques to sophisticated cell therapy approaches, CGT embodies the cutting edge of medical science, fueled by increased funding and novel ideas.

Join the Discussion at the Global Forum

Scheduled for November 20, the forum will coincide with the esteemed Jefferies London Healthcare Conference. Under the banner of "THE NEXT ERA OF CGT IS HERE," attendees can look forward to rich discussions on translating scientific achievements into meaningful patient outcomes.

Keynote Speakers Leading the Charge

The event promises to be enlightening with keynote addresses from some of the leading minds in CGT:

Dr. Craig Mello, a distinguished Nobel Laureate, will share insights from his groundbreaking work in RNA interference (RNAi), reflecting on how foundational scientific principles evolve into tangible therapeutic strategies. His presentation titled "RNAi: A Molecular Spark in an Information Inferno" will delve into the implications of RNA-based medicines in the evolving landscape of CGT.

Dr. Miguel Forte, a pivotal figure in clinical development, will discuss global perspectives on the challenges and hopes of CGT in his talk, "Crossing the Desert: Challenges and Reasons to Believe in Cell and Gene Therapy." His expertise will highlight the pivotal regulatory pathways and manufacturing intricacies shaping this dynamic field.

Panel Discussions: Insights from Industry Leaders

Attendees can expect engaging panel sessions that focus on critical areas influencing the trajectory of cell and gene therapy.

1st Panel: Navigating the Future of Cell Therapy

As cell therapy develops, various platforms, including autologous and allogeneic models, face unique challenges. This panel will showcase leading experts discussing innovative developments in cell therapy, featuring:

  • Ying Huang, CEO, Legend Biotech
  • Paul Stoffels, Former CSO, Johnson & Johnson
  • Paula Río, Head of the Bone Marrow Aplasia Unit
  • Marcello Maresca, Senior Director, AstraZeneca
  • Jonathan Esensten, Senior Advisor, Multiply Labs

2nd Panel: Gene Therapy and mRNA Therapeutics

This session will explore how innovative therapies are overcoming barriers in delivery and safety, reaffirming the potential for transformative treatments.

  • Sergio Linares, Unit Head, Sanofi
  • Luigi Calzolai, Scientific Officer, European Commission
  • Anna Cereseto, Head of Lab, University of Trento
  • Robin Shattock, Chair in Infection and Immunity, Imperial College

3rd Panel: Tackling Manufacturing Challenges in CGT

The complexities of CGT production can hinder progress. This panel will provide insights into strategies for enhancing manufacturing processes.

  • Jin Yin, CTO, ProBio
  • John Maher, Scientific Founder, Leucid Bio
  • Marten Hansen, Head of Laboratory, Sanquin

4th Panel: Aligning Innovation with Investment

Exploring the intersection of innovation and investments in the CGT field will be fundamental to driving sustainable business models. Panelists will share their views on navigating risks and opportunities ahead.

  • Laura Stoppel, Partner at RA Capital Management
  • Hongbo Lu, Founder, NextBio Capital

Final Call for Registrations

This is a unique opportunity for those involved in CGT to learn from the best in the industry and connect with fellow professionals. Participants will enjoy engaging keynote speeches, insightful panel discussions, and invaluable networking opportunities. Be part of this essential gathering to shape the future of cell and gene therapy.

Date: Thursday, November 20
Location: 116 Pall Mall, London, UK

Secure your complimentary ticket to this prestigious event!

Frequently Asked Questions

What is the GenScript Biotech Global Forum?

The forum is a gathering for professionals in the cell and gene therapy field to discuss innovations and challenges.

Who are the keynote speakers?

Notable speakers include Nobel Laureate Dr. Craig Mello and Dr. Miguel Forte from ISCT.

When is the event taking place?

The event will occur on November 20, 2025.

How can I register?

Registration is available online, and complimentary tickets are limited to the first 20 registrants.

What topics will be covered at the forum?

Topics include advancements in cell therapy, gene therapy, manufacturing challenges, and investment strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CHiQ Secures AI Award, Elevates Smart Home Living

Updated Category News Views 2

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Continue Reading
Testing Grounds: Navigating PRN Test Insights

Updated Category News Views 1

Deciphering the PRN Tester Repetition Today we're staring at what feels like déjà vu—a simple PR test peppered with the classic sentence about a fox and a dog. It's like someone left the 'repeat' function stuck on during a slow day at the office. But hey, let’s dig in. Is there something more behind this repetitive text, or are we grumbling at a wall? Unpacking the...

Continue Reading
VEVOR's Labor Day Salute to Home DIY Warriors

Updated Category News Views 4

Celebrating the DIY Spirit When most folks think of Labor Day, they picture grilling and lounging. But there's a whole crew out there wielding hammers and paintbrushes, making the most of their long weekend. That's right, Labor Day isn't just rest for some; it's a roll-up-your-sleeves and get it done kind of holiday, and VEVOR is tipping its hat to those folks. Home...

Continue Reading
HKC and KOORUI Shine Bright at 2026 Berlin Awards

Updated Category News Views 3

Display Titans Take Center Stage in Berlin Look, in this game of display tech, you either adapt or get left in the dust. At the 2026 Global Product Technology Innovation Awards in Berlin, we saw two names rise to the top—HKC and its acclaimed brand KOORUI. They didn't just show up; they grabbed the spotlight with two major honors. Award Spotlights: A Breakdown HKC took...

Continue Reading
Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 1

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
China Hour Expands Chinese Media Footprint in Africa

Updated Category News Views 2

An Ambitious Cross-Continental Media Play The airwaves are getting a new twist. This time, it's a blend of cultures, as China Hour makes an entrance in South Africa. That's right, folks—Jiangsu Broadcasting Corporation (JSBC) has set up camp alongside the South African Broadcasting Corporation (SABC), pushing a big media wave across the continent. If you've been...

Continue Reading
viaim's AI Earbuds Snag IFA Awards, Launch On Indiegogo

Updated Category News Views 1

When the tech cosmos hands you two hefty IFA Innovation Awards, you know you’re onto something. viaim’s Rise wasn't just about slick marketing—it brought home the 'Best in Audio' and 'Best in Design' titles from IFA 2026, proving these earbuds are more than just another gadget. Key Innovations Behind the Accolades IFA is no small affair—it's a major tech trade...

Continue Reading
Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Updated Category News Views 4

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 2

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
Haier Dives into AI-Powered Smart Homes at IFA 2026

Updated Category News Views 5

A Bold Step into the Future of Smart Homes Hold onto your hats, folks! Haier is making waves at IFA 2026, showing off smart home tech that's not just buzzing with AI but adapting right before our eyes. 'Home of Intelligent Possibilities' isn't just a catchy phrase—it's Haier promising us homes that think for themselves. From laundry to cooking, they’re tweaking those...

Continue Reading

Top 5 Most Recently Viewed Articles

Kinetics Begins Building High-Capacity FSRU for LNG

Updated Category News Views 8

Big Plans on the High Seas Here's another twist in the endless ocean of energy infrastructure milestones—Kinetics, the brainchild of Karpowership, is breaking ground, or rather, cutting steel in Singapore for its first high-capacity Floating Storage and Regasification Unit (FSRU). Just another day in the volatile world of LNG, right? This latest venture, tagged as LNGT...

Continue Reading
BranchOut Food Secures Key Funding to Propel Growth Forward

Updated Category News Views 169

BranchOut Food Secures Institutional Investment BranchOut Food Inc. (NASDAQ: BOF), a trailblazer in the food technology sector, has taken a significant step forward by announcing a $2.5 million institutional investment. This financing opportunity, comprised of 1,034,600 shares of common stock purchased by Bard Associates, Inc., is designed to bolster the company’s...

Continue Reading
Understanding NVIDIA's Options Trading Landscape and Insights

Updated Category News Views 251

Whales Show Bullish Sentiment on NVIDIA Recent trading data indicates that influential investors, often referred to as "whales," are adopting a significantly bullish outlook on NVIDIA. This trend raises questions about the future trajectory of the stock and its implications for investors. Examining NVIDIA's Trading Patterns A detailed look at the options trading history...

Continue Reading
Updates on Worldline's Voting Rights and Capital Structure

Updated Category News Views 164

Insights into Worldline's Voting Rights and Share Capital Understanding the structure of voting rights and shares in publicly traded companies is essential for investors and stakeholders alike. Worldline SA, a recognized leader in the payment services sector, recently provided a detailed account of its voting rights and total share capital. Company Information Overview...

Continue Reading
Biogen Faces Market Challenges, Stock Dips to 52-Week Low

Updated Category News Views 280

Biogen Inc. Stock Performance Analysis Biogen Inc. (NASDAQ: BIIB) stock has recently reached a low of $181.25, marking a significant dip in its journey over the past year. Currently, the stock has experienced a downward shift of approximately 24.53%, prompting a cautious sentiment among investors. This level is seen as a pivotal moment for shareholders and prospective...

Continue Reading